Gene
MTHFR
Last updated Sat May 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
What the gene does
MTHFR converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate (the form that donates a methyl group to homocysteine for re-methylation to methionine). Variants reduce enzyme activity:
- C677T TT: ~30% activity reduction.
- A1298C CC: smaller activity reduction.
- Compound heterozygotes have intermediate effects.
What the evidence actually shows
- Mild elevations in homocysteine (especially in folate-deficient populations).
- Possible small increase in neural tube defect risk — addressed by folic acid fortification.
- Cardiovascular and dementia risk: small effect sizes; B-vitamin supplementation generally doesn’t produce outcome benefit even when it lowers homocysteine.
- Pregnancy: routine MTHFR testing not recommended by most obstetric guidelines.
What MTHFR testing is over-marketed for
- "Detoxification" capacity: weak biological basis.
- Custom "methylated" supplements at premium prices: legitimate for documented B12/folate deficiency; not specifically required by MTHFR status in folate-replete adults.
- Cancer / autism / chronic fatigue links: not supported by high-quality evidence.
Reasonable interpretation
- TT homozygous + elevated homocysteine + low B12/folate intake: consider methylated forms (5-MTHF, methylcobalamin).
- TT homozygous + normal homocysteine: no action required.
- Routine MTHFR testing not recommended unless specific clinical context.
Related entries
References
- Long, S. & Goldblatt, J. MTHFR genetic testing: controversy and clinical implications. Aust. Fam. Physician 45, 237–240 (2016).